Harnessing cutaneous transcriptional and myeloid cell signatures to understand treatment response in juvenile dermatomyositis
利用皮肤转录和骨髓细胞特征来了解幼年皮肌炎的治疗反应
基本信息
- 批准号:10662089
- 负责人:
- 金额:$ 17.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-02 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:AdhesivesAffectAutoimmune DiseasesAutomobile DrivingBioinformaticsBiological MarkersBiologyBiopsyBloodBlood specimenCalcinosisCaringCellsCellular biologyChildChildhoodChronicChronic DiseaseClinicalCutaneousDataDermalDermatologicDevelopmentDiagnosisDiseaseEnrollmentExanthemaFlareFunctional disorderFundingGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGoalsHeterogeneityIdiopathic Inflammatory MyopathiesImmuneImmune systemImmunologyInflammationInflammation MediatorsInflammatoryInvestigationJuvenile DermatomyositisKnowledgeLifeLongitudinal cohortLung diseasesMacrophageMediatorMentorsMethodologyMethodsMichiganModelingMolecularMolecular AnalysisMolecular DiseaseMolecular TargetMonitorMuscleMuscle WeaknessMyelogenousMyeloid CellsMyopathyMyositisOrganOutcomePathologicPathologyPathway interactionsPatient CarePatientsPatternPeripheral Blood Mononuclear CellPhenotypePhysiciansPopulationPrognostic MarkerProspective cohortProteinsRNARefractoryResearchResearch DesignResearch PersonnelResidual stateResolutionRoleSamplingScientistSignal TransductionSkinSymptomsSystemic diseaseSystems BiologyTechniquesTherapeutic immunosuppressionTissuesTrainingTranslational ResearchTreatment Side EffectsUniversitiesWritingbiobankbiomarker developmentcareercareer developmentcohortimprovedindividual patientinsightintercellular communicationkeratinocytenon-invasive monitornovelnovel markeroral communicationpatient orientedperipheral bloodprecision medicineprofessorresponseresponse biomarkerrheumatologistsingle-cell RNA sequencingskillsskin disordersupport toolssystemic inflammatory responsetargeted treatmenttherapeutic targettranscriptometranscriptome sequencingtranscriptomicstreatment response
项目摘要
PROJECT SUMMARY/ABSTRACT
Juvenile dermatomyositis (JDM) is a potentially life-threatening pediatric autoimmune disease that frequently
first presents with cutaneous inflammation and can progress to debilitating muscle weakness, calcinosis, and
severe lung disease. Two-thirds of children do not respond to initial treatment, and there is a lack of prognostic
biomarkers and targeted treatments. Thus, there is a critical need to develop a better understanding of cellular
disease mechanisms and molecular heterogeneity to advance precision medicine. Deeper investigation of
molecular disease signatures at the tissue level, where active inflammation frequently persists, holds the
potential to delineate novel disease mechanisms, biomarkers and treatment targets. The specific scientific aims
of this project are to 1) Utilize cutaneous and peripheral blood gene expression signatures to determine biology
and predictors of JDM treatment response and 2) Determine single-cell and spatial transcriptional phenotypes
of myeloid cells within skin and blood that are associated with treatment refractory JDM. Through a longitudinal
approach and non-invasive skin sampling methodology in a well-phenotyped JDM cohort, the candidate will
characterize cutaneous transcriptomic signatures in both lesional and non-lesional skin as related to treatment
response. The candidate will leverage paired blood samples to directly compare the importance of tissue-specific
signatures in biomarker development. Cutaneous myeloid cell populations in treatment refractory JDM patients
will additionally be assessed at a single-cell level with spatial resolution to better understand the potential role of
myeloid cells as mediators of cutaneous inflammation and dermal-systemic immune crosstalk. The applicant is
an Assistant Professor and Pediatric Rheumatologist at the University of Michigan and actively treats children
with JDM. Her long-term career goal is to advance knowledge of disease mechanisms, identify novel biomarkers
and discover therapeutic targets in JDM in order to improve care for her patients. To become an independent
physician scientist with expertise in molecular and cellular mechanisms of pediatric autoimmune disease, the
candidate will accomplish the following scientific training goals: 1) gain expertise in working with additional patient
biosamples and primary cells, specifically using keratinocytes and myeloid cells, as a model to study immune
dysregulation in JDM, 2) develop skills in the application of bioinformatic, single-cell and systems biology
approaches to the study of pediatric autoimmune disease, and 3) gain expertise in study design, integration and
analysis of molecular and clinical patient-oriented data. The candidate will also complete the following career
development goals: 1) develop skills to lead a translational research team and mentor trainees, 2) improve written
and oral communication skills and 3) establish a multicenter research network. The applicant has formed an
engaged team of mentors and advisors with expertise in keratinocyte biology, immunology, bioinformatics,
single-cell methods and systems biology approaches to integration of patient-oriented data to guide her in the
proposed study and career development goals.
项目摘要/摘要
青少年皮肌炎(JDM)是一种潜在的威胁生命的儿科自身免疫性疾病
首先出现皮肤炎症,并可以发展为使肌肉无力,钙化和
严重的肺部疾病。三分之二的儿童对初始治疗没有反应,并且缺乏预后
生物标志物和靶向治疗。因此,迫切需要更好地理解细胞
疾病机制和分子异质性,以促进精确医学。更深入的研究
在组织水平上的分子疾病特征,活动炎症经常持续存在
潜力描绘出新的疾病机制,生物标志物和治疗靶标。具体的科学目的
该项目的时间为1)使用皮肤和周围血液基因表达特征来确定生物学
以及JDM治疗反应的预测指标和2)确定单细胞和空间转录表型
与治疗难治性JDM有关的皮肤和血液中的髓样细胞的。通过纵向
在良好的JDM队列中,方法和非侵入性皮肤采样方法,候选人将
表征与治疗有关
回复。候选人将利用配对的血液样本直接比较组织特异性的重要性
生物标志物开发中的签名。治疗难治性JDM患者的皮肤髓样细胞群
另外将在单细胞水平和空间分辨率的单细胞水平上进行评估,以更好地了解
髓样细胞作为皮肤炎症和皮肤化系统性免疫串扰的介体。申请人是
密歇根大学的助理教授兼儿科流变学家,并积极对待儿童
与JDM。她的长期职业目标是提高人们对疾病机制的了解,确定新颖的生物标志物
并发现JDM中的治疗靶标,以改善患者的护理。成为独立
医师科学家在小儿自身免疫性疾病的分子和细胞机制方面具有专业知识,
候选人将实现以下科学培训目标:1)获得与其他患者合作的专业知识
生物样本和原代细胞,特别使用角质形成细胞和髓样细胞作为研究免疫的模型
JDM中的失调,2)发展生物信息,单细胞和系统生物学的技能
小儿自身免疫性疾病研究的方法,3)在研究设计,整合和
分子和临床面向患者数据的分析。候选人还将完成以下职业
发展目标:1)发展技能以领导转化研究团队和导师学员,2)改进书面
和口头沟通技巧以及3)建立多中心研究网络。申请人形成了
参与指导者和顾问团队具有角质形成生物学,免疫学,生物信息学专业知识,
单细胞方法和系统生物学方法是集成患者的数据,以指导她
拟议的研究和职业发展目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Leigh Turnier其他文献
Jessica Leigh Turnier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
系统性红斑狼疮患者泌乳素对调节性B细胞的调控作用及其影响自身抗体分泌的研究
- 批准号:81803129
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
活性氧ROS在调节性B细胞分化中的作用及其对于自身免疫性疾病的影响
- 批准号:81771736
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
自身抗体1G3调控DDX5对血脑屏障通透性的影响及机制研究
- 批准号:81601428
- 批准年份:2016
- 资助金额:17.5 万元
- 项目类别:青年科学基金项目
miR-186参与Th17/Treg失衡及影响毛囊干细胞活化在重症斑秃中的机制研究
- 批准号:81673074
- 批准年份:2016
- 资助金额:70.0 万元
- 项目类别:面上项目
自身免疫性疾病相关炎症因子对CD8+ T细胞再次应答的影响
- 批准号:81072421
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
白细胞整合素信号的改变导致糖尿病和自身免疫
- 批准号:
10683384 - 财政年份:2022
- 资助金额:
$ 17.28万 - 项目类别:
Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis
项目 3-白细胞-血小板相互作用在炎症和血栓形成中的作用
- 批准号:
10661640 - 财政年份:2021
- 资助金额:
$ 17.28万 - 项目类别:
Sublingual Supramolecular Vaccines and Immunotherapies
舌下超分子疫苗和免疫疗法
- 批准号:
10671694 - 财政年份:2021
- 资助金额:
$ 17.28万 - 项目类别:
Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis
项目 3-白细胞-血小板相互作用在炎症和血栓形成中的作用
- 批准号:
10471914 - 财政年份:2021
- 资助金额:
$ 17.28万 - 项目类别:
BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION
用于干细胞衍生的 β 细胞移植的生物材料
- 批准号:
10684716 - 财政年份:2021
- 资助金额:
$ 17.28万 - 项目类别: